Nomen | Pregabalin |
Cas numerum | 148553-50-8 |
MOLECULA | C8h17no2 |
Pondus | 159.23 |
Einecs numerus | 604-639-1 |
PRAETERITUS | 274.0 ± 23.0 ° C |
Pudicitia | XCVIII% |
Repono | Signatum in sicco, locus temperatus |
Forma | Pulverem |
Colo | Alba |
Stipare | PE lapides sacculi + Aluminium |
III (s) - (Aminomethyl) -5-methylhexanoic acidum (3s) -3- (aminomethyl) -5-methylhexanoic acidum, pregabalin, pregablin, 3- (aminomethyl) -5, methyl, 3- (aminomethyl) -5-methyl, 3- (R ) -Pregabalin (S) -Pregabalin
Pharmacological effectus
Pregabalin habet bonum therapeutica effectus in comitialibus. Studiis in variis animalis epileptici masculorum exempla ostensum est quod pregabalin potest significantly ne epileptici caducis, et activae dose est 3-10 temporibus inferioribus quam Gabapentin. Studiis invenerunt quod pregabalin redigendum sensitivam et motor medulla spinalis reflexes rat premunt-pollicem STIMULUM, reducere ad partum de neuropathic animalis dolor exempla et diabetes, periphericis nervi injuriam vel chemotherapy et inhibere vel reducere dolorem et inhibere vel inhibere dolor Medulla stimulos. mores. Animal studiis invenerunt quod pregabalin ut commoda respectu cum opioids. Pregabalin providet novum optionem ad orci curatio neuropathic dolor.
Mechanism
Pregabalin ut redigendum calcium, dependens release de aliquo neurotransmitters per modulating calcium channel munus. Licet Pregabalin est structural inde inhibaction of inhibitory neurotransmitter γ-aminobutyric acid (Gaba), non directe ligare ad Gabaa, Gabaa in cultus neurons et non auget Gabaa in cultus neurons reactionem, non est in concentionem et non auget Gabaa in cultus et non auget Gabaa in reactionem, non mutare in cultus in Gaba reactionem, non est mutare concentionem Gaba reactionem, non est mutare Gaba, et non est in cultus et non auget Gabaa in reactionem Cerebrum mures, et non habet acutum effectum in Gaba uptake et degradation. Tamen, studium invenit quod longius nuditate excultus neurons ad pregabalin augeri densitate Gaba Transporters et rate of eget Gaba onerariam. Pregabalin does not block sodium channels, has no activity on opioid receptors, does not alter cyclooxygenase activity, has no activity on dopamine and serotonin receptors, and does not inhibit the reactivation of dopamine, serotonin, or norepinephrine. Ingest.
Medicina interactiones
I. Non metabolized a Cytochrome P450 ratio ergo raro interacts cum aliis medicamento. Non afficit pharmacokinetics de Antiepileptic medicamentis (ut sodium valproate, Phenytoin, Lamotrigine, Carbazepine, Phenobarbital, Topiramate), oralis contraceptives, oralis, oralis, oralis, oralis, oralis, et insulin.
II. Cum hoc productum adhibetur una cum oxycodone, eius recognitionem munus erit reduci et motor munus damnum erit auctus.
III. Eam habet EXPECTATIO effectus cum Lorazepam et Ethanol.